28(top 2%)
papers
158(top 5%)
citations
8(top 5%)
h-index
13(top 5%)
g-index
40
all documents
189
doc citations
112
citing journals

Top Articles

#TitleJournalYearCitations
1Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma nicheJournal of Leukocyte Biology201731
2Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysisTransplant Infectious Disease202228
3Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple MyelomaCancer Immunology Research201524
4Brief Report: Mesenchymal Stromal Cell Atrophy in Coculture Increases Aggressiveness of Transformed CellsStem Cells201321
5Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC SourceFrontiers in Immunology202019
6Human embryonic stem cell–derived mesenchymal stromal cellsTransfusion201118
7MAP3K8 kinase regulates myeloma growth by cell‐autonomous and non‐autonomous mechanisms involving myeloma‐associated monocytes/macrophagesBritish Journal of Haematology201312
8Outcomes with allogeneic hematopoietic stem cell transplantation in TP53-mutated acute myeloid leukemia: a systematic review and meta-analysisLeukemia and Lymphoma202210
9Leveraging Antiprogestins in the Treatment of Metastatic Breast CancerEndocrinology20218
10Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapiesLeukemia and Lymphoma20226
11Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL)Blood20214
12Mice Expressing MYC and NrasQ61R in Germinal Center B Cells Develop Highly Aggressive Multiple MyelomaBlood20183
13Selinexor-Based Regimens in Patients with Multiple Myeloma after Prior Anti-B-Cell Maturation Antigen TreatmentBlood20213
14Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)Blood20212
15Reconstructing the Clonal and Mutational Architecture of Myeloma through Avian Leukosis Virus (ALV)-Mediated Genome EditingBlood20180
16Use of Endpoints in Phase III Randomized Controlled Trials for Acute Myeloid Leukemia over the Last 15 Years: A Systematic ReviewBlood20210
17Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-AnalysisBlood20210
18Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisBlood20210
19Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-AnalysisBlood20210
20Outcomes with Hematopoietic Stem Cell Transplantation in Secondary Hemophagocytic Lymphohistiocytosis: A Systematic Review and Meta-AnalysisBlood20210
21Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisBlood20210
22Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation over the Last 15 Years: A Systematic ReviewBlood20210
23Outcomes with Natural Killer Cells Infusion after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisBlood20210
24Outcomes with Mismatched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Following Reduced Intensity Conditioning: A Systematic Review and Meta-AnalysisBlood20210
25Top 100 Cited Articles on Hematopoietic Stem Cell Transplantation: A Bibliometric AnalysisBlood20210
26Differentiation of a CD4/CD8αβ Double Positive T Cell Population from the CD8 Pool Is Both Predictive and Sufficient to Mediate Graft-Vs-Host DiseaseBlood20210
27Developing Novel Targeted Therapies Using the High-Risk Vq Myeloma ModelBlood20200
28Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysisLeukemia and Lymphoma20220